Abstract
Premature coronary artery disease (CAD) is common in India. We, therefore, studied oxidative stress, dyslipidemia, and high sensitivity-C reactive protein (hs-CRP) levels in young CAD patients. Present study consisted of male CAD patients below 40 years and age and sex matched healthy controls (n=30 each). Fasting blood samples were analyzed for serum lipid profile, malondialdehyde, antioxidant enzymes and hs-CRP levels. Dyslipidemia was observed in 90% of the young CAD patients, of which 72.2% showed increased serum triglycerides and decreased HDL-cholesterol. LDL-cholesterol levels were high in 77.8%. Serum malondialdehyde and hs-CRP levels were increased significantly (p<0.0001) as compared to controls. hs-CRP levels were in high risk range in all the young patients. However, glutathione peroxidase activity was reduced significantly (p<0.05). Our data suggests that elevated hs-CRP levels along with dyslipidemia and oxidative stress adds to the predictive value of premature CAD in young Indians.
Key Words: Dyslipidemia, high sensitivity-C reactive protein, Premature CAD, Malondialdehyde
Full Text
The Full Text of this article is available as a PDF (114.4 KB).
References
- 1.Yusuf S., Hawken S., Ounpuu S., Dans T., Avezum A., Lanas F., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART STUDY) Lancet. 2004;364:937–952. doi: 10.1016/S0140-6736(04)17018-9. [DOI] [PubMed] [Google Scholar]
- 2.Mutlu-Turkoglu U., Akalin Z., Ilhan E., Yilmaz E., Bilge A., Nisanci Y., Uysal M. Increased plasma malondialdehyde and protein carbonyl levels and lymphocyte DNA damage in patients with angiographically defined coronary artery disease. Clin Biochem. 2005;38:1059–1065. doi: 10.1016/j.clinbiochem.2005.07.001. [DOI] [PubMed] [Google Scholar]
- 3.Serdar Z., Aslan K., Dirican M., Sarandol E., Yesilbursa D., Serdar A. Lipid and protein oxidation and antioxidant status in patients with angiographically proven coronary artery disease. Clin Biochem. 2006;39:794–803. doi: 10.1016/j.clinbiochem.2006.02.004. [DOI] [PubMed] [Google Scholar]
- 4.Beutler E., Duron O., Kelly B. Improved method for the determination of blood glutathione. J Lab Clin Med. 1963;61:882–888. [PubMed] [Google Scholar]
- 5.Paglia D.E., Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70:158–169. [PubMed] [Google Scholar]
- 6.Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chem Acta. 1978;90:37–43. doi: 10.1016/0009-8981(78)90081-5. [DOI] [PubMed] [Google Scholar]
- 7.Summary of the third report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA. 2001;285:2486–2497. doi: 10.1001/jama.285.19.2486. [DOI] [PubMed] [Google Scholar]
- 8.Ridker P. Clinical application of C - reactive protein for cardiovascular disease detection and prevention. Circulation. 2003;107:363–369. doi: 10.1161/01.CIR.0000053730.47739.3C. [DOI] [PubMed] [Google Scholar]
- 9.Espliguero R.A., Avanzas P., Sales J.C., Aldama G., Pizzi C., Kaski J.C. C-reactive protein elevation and disease activity in patients with coronary artery disease. Eur Heart J. 2004;25:401–408. doi: 10.1016/j.ehj.2003.12.017. [DOI] [PubMed] [Google Scholar]
- 10.Kip K.E., Marroquin O.C., Shaw L.J. Global inflammation predicts cardiovascular risk in women: A report from the Women’s Ischemia Syndrome Evaluation (WISE) study. Am Heart J. 2005;150:900–905. doi: 10.1016/j.ahj.2005.02.002. [DOI] [PubMed] [Google Scholar]